Skip to main content
SNDX logo

SNDX

Syndax Pharmaceuticals Inc
$22.89 -0.72 (-3.05%) At close · Jul 13
Market Cap
$2.03B
Shares
88,610,027

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 247
Total Value: $2,305,077,424
Total Shares: 98,721,432
Showing 1–100 of 261 holdings by value · page 1 of 3

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 246 13F filers
Top Holder
8.4%
Jun 2023 → Mar 2026 · range 8.1% – 10.5%
of institutional value
Top 5
30.5%
Jun 2023 → Mar 2026 · range 29.5% – 33.8%
of institutional value
Top 10
46.1%
Jun 2023 → Mar 2026 · range 45.1% – 53.1%
of institutional value
HHI
310
Jun 2023 → Mar 2026 · range 304 – 387
Broadly held
Showing 100 of 261
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1395937 CUSIP 87164F105 13F (30d) 11 filings 10 filers Visit website Investor relations